|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2014062318202N1 |
|
Date of registration:
|
2014-07-10 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer.
|
|
Scientific title:
|
The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer. |
|
Date of first enrolment:
|
2014-08-01 |
|
Target sample size:
|
32 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/16580 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Poland
| | | | | | | |
|
Contacts
|
|
Name:
|
Judyta Zabielska
|
|
Address:
|
ul. Trzy lipy 3
80-172
Gdansk
Poland |
|
Telephone:
|
0048585858800 |
|
Email:
|
judyta.zabielska@invicta.pl |
|
Affiliation:
|
Invicta Gdansk |
|
|
Name:
|
Judyta Zabielska
|
|
Address:
|
GPNT ul. Trzy lipy 3
80-172
Gdansk
Poland |
|
Telephone:
|
0048585858800 |
|
Email:
|
judyta.zabielska@invicta.pl |
|
Affiliation:
|
Invicta Fertility and Reproductive Centre |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Incusion: 1. Patients undergoing assisted reproductive treatment with intracytoplasmic sperm injection and frozen blastocyst embryotransfer in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 09.2014
Exclusion: 1. Blastocysts in stages 2CC, 3CC, 4CC, and 5CC did not qualify for biopsy.
2.Patients in whom no normal embryo was available
Exclusion criteria:
Age minimum:
33 years
Age maximum:
42 years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Female infertility, unspecified
|
Infertility.
Female infertility, unspecified
|
|
Intervention(s)
|
|
Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection
|
|
Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection.
|
|
Diagnosis
|
|
Primary Outcome(s)
|
|
Pregnancy rate. Timepoint: on 6 weeks and 1-3 days. Method of measurement: clinical poregnancy (as ultrasound fetal heartbeat detection).
|
|
Secondary Outcome(s)
|
|
Implantation rate. Timepoint: 7 day after tansfer. Method of measurement: blood serum beta-HCG concentration.
|
|
Source(s) of Monetary Support
|
|
Invicta s.z o.o.
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Komisja Bioetyczna przy Okregowej Izbie Lekarskiej
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|